Fetal death from SARS-CoV-2 mediated acute placental failure

J Reprod Immunol. 2023 Aug:158:103958. doi: 10.1016/j.jri.2023.103958. Epub 2023 May 18.

Abstract

Introduction: We demonstrate the nonlinear severity of symptoms of SARS-CoV-2 infection in the mother leading to fetal death after acute placental failure.

Methods: Careful clinical evaluation, real-time RT-PCR molecular microbiologic testing, isolation of a viable virus, and autopsy with histologic results were used to investigate the possible vertical transmission of SARS-CoV-2 infection from mother to fetus.

Results: Histologic changes in the placenta correlate with SARS-CoV-2 infection. Total nucleic acid isolated from vaginal swabs, fresh placental tissue, and deparaffinized tissue showed a high viral load of SARS-CoV-2. Complete genome sequencing confirmed the presence of the SARS-CoV-2 Delta variant.

Discussion: Several methods have been used to confirm SARS-CoV-2-mediated acute placental failure, all of which were conclusive. It should be noted that careful periodic fetal well-being checks are required in women infected with SARS-CoV-2, regardless of the severity of symptoms. Most of the cases described with fetal death occurred in the third trimester.

Keywords: Covid-19; Delta variant; Fetal death; Placenta; SARS-CoV-2.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • COVID-19* / complications
  • COVID-19* / virology
  • Female
  • Fetal Death* / etiology
  • Humans
  • Placenta* / pathology
  • Placenta* / virology
  • Pregnancy
  • Pregnancy Complications, Infectious* / virology
  • SARS-CoV-2 / genetics

Supplementary concepts

  • SARS-CoV-2 variants